SUBJECT_IDENTITY:

Stéphane BancelExecutive Portfolio & SEC Filing Analysis

Quantitative tracking of individual C-Suite capital flows and historical trading performance.

Overall Action / Bias
NET LIQUIDATION
SOURCE: SEC_EDGARSTATUS: VERIFIED

Automated_Intelligence_Dossier :: Stéphane Bancel

Based on the latest data extracted directly from the Securities and Exchange Commission (SEC) EDGAR database, this page provides a comprehensive breakdown of the insider trading activity associated with Stéphane Bancel. Tracking the liquidity events of Tier-1 corporate insiders provides critical asymmetric market intelligence.

During the analyzed reporting window, the subject has been formally affiliated with and executed transactions across 1 public entity. The primary market vehicles involved in these Form 4 filings are: MRNA.

Our quantitative models calculate an aggregate nominal transaction volume of $1094.03M USD across all associated tickers. By isolating voluntary open-market purchases against voluntary open-market sales (excluding automated tax withholdings and option grants), the portfolio exhibits a negative capital flow of $1071.56M USD. This structural dynamic results in an overall classification of NET LIQUIDATION for the executive's current market posture.

* Note: The SEC requires all directors, officers, and principal stockholders (holding more than 10% of a company's equity) to file a Form 4 detailing their transactions within two business days. The data below reflects these mandatory disclosures.

Affiliated_Tickers

1

PUBLIC COMPANIES
Filing_Events

200

TOTAL TRANSACTIONS LOGGED
Latest_Filing

2026.02.11

ISO_8601 FORMAT

Corporate_Affiliations_Overview

MRNA

Volume:$1094.0M
Transactions:1084
Last Active:2026.02.11
Loading chart...
Entity / TimelineTransaction TypeSharesMarket Move 30DNominal Value
Bancel StephaneDirector2026.02.11 · CODE_F
TAX_WITHHOLDING
5,450+29.7%$228,845.50
Bancel StephaneDirector2026.02.11 · CODE_A
EQUITY_AWARD
11,271+29.7%$0.00
Bancel StephaneDirector2025.12.11 · CODE_M
OPTION_EXERCISE
688,073+14.2%$7,499,995.70
Bancel StephaneDirector2025.03.03 · CODE_P
OPEN_MARKET_BUY
57,493-8.4%$1,812,754.29
Bancel StephaneDirector2025.03.03 · CODE_P
OPEN_MARKET_BUY
102,821-8.4%$3,191,563.84
Bancel StephaneDirector2025.02.12 · CODE_F
TAX_WITHHOLDING
6,400+13.4%$197,952.00
Bancel StephaneDirector2025.02.12 · CODE_A
EQUITY_AWARD
13,233+13.4%$0.00
Bancel StephaneDirector2024.06.14 · CODE_J
SEC_CODE_J
26,840-13.2%$0.00
Bancel StephaneDirector2024.02.16 · CODE_S
OPEN_MARKET_SALE
26,351+18.0%$2,342,097.96
Bancel StephaneDirector2024.02.14 · CODE_A
EQUITY_AWARD
56,736+20.8%$0.00
Bancel StephaneDirector2023.09.15 · CODE_J
SEC_CODE_J
17,893-19.8%$0.00
Bancel StephaneDirector2023.06.28 · CODE_S
OPEN_MARKET_SALE
366-3.5%$45,036.30
Bancel StephaneDirector2023.06.28 · CODE_S
OPEN_MARKET_SALE
13,094-3.5%$1,597,598.94
Bancel StephaneDirector2023.06.28 · CODE_S
OPEN_MARKET_SALE
11,417-3.5%$1,386,023.80
Bancel StephaneDirector2023.06.28 · CODE_S
OPEN_MARKET_SALE
2,278-3.5%$274,248.42
Bancel StephaneDirector2023.06.28 · CODE_M
OPTION_EXERCISE
27,155-3.5%$26,883.45
Bancel StephaneDirector2023.06.22 · CODE_S
OPEN_MARKET_SALE
15,171+2.1%$1,818,547.77
Bancel StephaneDirector2023.06.22 · CODE_S
OPEN_MARKET_SALE
24,829+2.1%$2,957,878.77
Bancel StephaneDirector2023.06.22 · CODE_M
OPTION_EXERCISE
40,000+2.1%$39,600.00
Bancel StephaneDirector2023.06.21 · CODE_S
OPEN_MARKET_SALE
19,289+4.4%$2,357,308.69
PAGE_ 1 _OF_ 10

Frequently Asked Questions

>Should investors follow Stéphane Bancel's trades?

Insider trades by Stéphane Bancel across MRNA can signal executive conviction, but should be evaluated alongside open-market vs. planned (10b5-1) transaction types.

>Is Stéphane Bancel currently buying or selling stock?

Based on recent SEC Form 4 filings, Stéphane Bancel's overall market bias is classified as NET LIQUIDATION, with a net capital flow of $1071.56M USD.

>Which companies is Stéphane Bancel affiliated with?

Stéphane Bancel is affiliated with and has executed transactions in 1 public companies: MRNA.

Related_Analysis

Associated Tickers
MRNA
Glossary
SEC Form 4View all terms